Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin
about
Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3Myocilin mediates myelination in the peripheral nervous system through ErbB2/3 signalingNeuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous systemA tyrosine kinase profile of prostate carcinomaMimotope vaccination--from allergy to cancerCharacterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampusA hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factorInteraction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulinNeuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1Development of adenovirus capsid proteins for targeted therapeutic deliveryA MultiSite Gateway Toolkit for Rapid Cloning of Vertebrate Expression Constructs with Diverse Research Applications.Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.A Sox10 expression screen identifies an amino acid essential for Erbb3 function.The ErbB4 receptor in fetal rat lung fibroblasts and epithelial type II cellsNeuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapsesThe cellular response to neuregulins is governed by complex interactions of the erbB receptor familyDiversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactionsErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancerControlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimersErbB expression: the mouse inner ear and maturation of the mitogenic response to heregulin.Dynamically varying interactions between heregulin and ErbB proteins detected by single-molecule analysis in living cellsAxon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2.HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cellsEnhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cellsArecoline induced disruption of expression and localization of the tight junctional protein ZO-1 is dependent on the HER 2 expression in human endometrial Ishikawa cells.Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.DNA methylation changes in a human cell model of breast cancer progression.Ligand-directed retroviral targeting of human breast cancer cells.RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in ratsHeregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.Bivalence of EGF-like ligands drives the ErbB signaling networkThe C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growthOncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy.Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factorFOXO1A is a target for HER2-overexpressing breast tumors.
P2860
1e5ecb2f1229e07899ad962fe46ffd7de4d1c3d230aed0b7e2870673a6172548e05d4bbf414d8d9c3f1657e5b87e1bbc02ef87f189d30bbcffee45094914e4415497b6f26a8f2d90374e11ca39e38e0493997013d16119196135cbe8c1551ebcc1e21d3cbce4ebd89be0c7d065be9f39821f80e51cce29eac87edeb33a95e63e2cbdf9f92e34143b4adaa8edd353ce75d7d4e5a2eed4bbed3dd51799542d5e0f
P248
Q24309266-B330E516-87FD-4F90-8C16-9847AF907FF1Q24313038-6B3959A6-3741-4D9D-808F-AB113A6BEB46Q24336447-79F69475-6D79-430F-AE2C-93509D4F9167Q24601534-8062B65E-AAA2-4538-8BF0-2121EBDF46A9Q24607795-35BD7978-A63C-446A-9D17-C65ABF24D9DBQ24608624-C1BDB602-B199-4A71-BFEA-893285D55F88Q24645951-759D7701-F0F6-4007-A17D-AEB5D03D02B7Q24648517-539BF9B6-5649-47C0-9EA7-E4AFD6A7CC3DQ24649294-695C4EAB-D1E7-4ABB-A7E2-7A2B2BC9DC18Q24681497-A9C9CCA7-C42E-4546-8F40-4ADBD85D0560Q27010557-E0CD1097-A2F8-48BD-BA3B-3FB783209EF0Q27334567-7E78F501-A58B-4914-BB9B-7CB1396C0029Q27851691-A51A365C-E79E-4DD4-8AB9-9DB75947322FQ28473562-458BF357-00A0-4251-9E52-27EA2EAC1E76Q28564324-BE6EF499-D3AA-46D1-9785-DE1A43332279Q28576249-26A89415-92F9-45B8-93B5-7677D9D83435Q28609130-32448652-8C2F-4DB8-86F9-21985123609DQ28609149-1F34E346-CA05-493C-924D-CEFB365CDBE1Q28678776-8DFA38FE-6B71-48DE-81C0-97A0FDDF3CDDQ28679173-5D3C25BA-5FE8-4645-A325-A4BD1A52E2D2Q30473444-FA2FCC5F-BB04-41F1-89DE-8536CEE7235DQ30524738-A2D8E913-2D39-4570-A1AA-5F85578F2CECQ30530901-B279F1F7-E55D-45CD-8F3C-5EDFA7BC3EBFQ33514127-B40D8A4B-DA2A-4DED-8FBD-A0A8891863ECQ33538332-7A7743AE-D352-4298-A1B5-4CE575D8961EQ33626062-96CE5B46-AE46-404C-AE57-6E07F0FE721BQ33664216-6A62335E-08FE-4B21-A4D8-061EC404885CQ33692428-7BDA5D5D-0B30-4148-B4E7-EC002D0C4567Q33781099-180C6C7D-F32F-4F85-86FC-50A2E2AB156BQ33857557-E3DAE7FC-FD93-48F4-B8DB-D42DA0F4178FQ33868131-4697F3BB-AF1D-401E-AFCB-EECA4642FD6DQ33882396-C1EA007A-2B43-425E-855E-19CBD6A94B2EQ33886118-CBE0B331-C8A1-4F53-86D1-BE7E74AC6534Q33886341-8718F0E4-614D-4D80-9AC4-A3DDEFC19AE7Q33887274-C238889F-A1CB-4042-B385-66EC528FA66EQ33891080-1AB65CCF-C50C-4359-BACC-B30705835ED6Q33911239-95CD967F-583C-4C83-924B-01AD499B5ADCQ33943421-40A6C9DE-6E82-421C-AF99-6063F1BF68ADQ33957454-43E25FBB-E6D9-4CE6-B4CB-3DAED4EA3909Q33959090-65B04FF9-4B8E-4765-B2DC-B3CEE6E0DD0A
P2860
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@ast
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@en
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@en-gb
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@nl
type
label
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@ast
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@en
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@en-gb
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@nl
prefLabel
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@ast
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@en
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@en-gb
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@nl
P2093
P3181
P1476
Coexpression of erbB2 and erbB ...... ffinity receptor for heregulin
@en
P2093
B M Fendly
G Schaefer
J A Lofgren
K L Carraway
M X Sliwkowski
R A Cerione
R L Vandlen
V D Fitzpatrick
P304
P3181
P407
P577
1994-05-20T00:00:00Z